- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06306105
Assessment of Anti-aging Efficacy of Marine Collagen Peptides
March 15, 2024 updated by: TCI Co., Ltd.
To assess the anti-aging efficacy of Marine Collagen Peptides on skin, hair and finger nails for human
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Chia-Hua Liang, Ph.D.
- Phone Number: 2441 +886-06-2664911
- Email: tinna_ling@mail.cnu.edu.tw
Study Contact Backup
- Name: Ping Lin
- Phone Number: +886-02-879778111
- Email: candice.lin@tci-bio.com
Study Locations
-
-
-
Pingtung, Taiwan, 928
- Recruiting
- Chia Nan University of Pharmacy & Science
-
Contact:
- Chia-Hua Liang
- Phone Number: 2441 +886-06-2664911
- Email: tinna_ling@mail.cnu.edu.tw
-
Contact:
- Ping Lin
- Phone Number: +886-02-879778111
- Email: candice.lin@tci-bio.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Healthy adults aged above 18 years old
Exclusion Criteria:
- Subjects who are not volunteers
- Subjects who have been diagnosed with dermatitis, cirrhosis, and chronic kidney failure
- Subjects who have known cosmetic, drug or food allergies.
- Patients are taking medicine for chronic diseases
- Subjects receiving treaments for scalp, hair transplant, and other scalp medical care in past 12 weeks.
- Subjects getting a manicure and perm in past 12 weeks.
- Female who is pregnant or nursing or planning to become pregnant during the course of the study.
- Subjects receiving facial laser therapy, chemical peeling or UV overexposure (> 3 hr/week) in the past 12 weeks.
- Students who are currently taking courses taught by the principal investigator of this trial.
- Subjects are not willing to reveal the results of pictures after taking the product
- Vegetarian.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Placebo Comparator: placebo drink
|
consume 1 bottle per day
|
Experimental: Marine Collagen Peptides drinks
|
consume 1 bottle per day
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The change of skin collagen density
Time Frame: Change from Baseline skin collagen density at 12 weeks
|
DermaLab® Series SkinLab Combo was utilized to measure skin collagen density.
Units: arbitrary units
|
Change from Baseline skin collagen density at 12 weeks
|
The change of skin hydation
Time Frame: Change from Baseline skin skin hydation at 12 weeks
|
Corneometer® CM825 (CK, Germany) was utilized to measure skin surface hydation.
Units: arbitrary Corneometer® units 0-120.
|
Change from Baseline skin skin hydation at 12 weeks
|
The change of skin wrinkles
Time Frame: Change from Baseline skin wrinkles at 12 weeks
|
VISIA Complexion Analysis was utilized to measure skin wrinkles.
Units: the amount of detectable wrinkles
|
Change from Baseline skin wrinkles at 12 weeks
|
The change of skin elasticity
Time Frame: Change from Baseline skin elasticity at 12 weeks
|
Cutometer® MPA580 was utilized to measure skin elasticity.
Units: visco-elasticity in %.
|
Change from Baseline skin elasticity at 12 weeks
|
The change of hair diameters
Time Frame: Change from Baseline hair diameters at 12 weeks
|
Mitutoyo C/N293-100 was utilized to measure hair diameters.
Units: millimeter
|
Change from Baseline hair diameters at 12 weeks
|
The change of hair loss amount
Time Frame: Change from Baseline hair loss amount at 12 weeks
|
Collect and measure the weight of loss hair.
Units: gram
|
Change from Baseline hair loss amount at 12 weeks
|
The change of hair roots diameters
Time Frame: Change from Baseline hair roots diameters at 12 weeks
|
Mitutoyo C/N293-100 was utilized to measure hair roots diameters.
Units: millimeter
|
Change from Baseline hair roots diameters at 12 weeks
|
The change of hair density
Time Frame: Change from Baseline hair density at 12 weeks
|
Soft Plus was utilized to picture and observe hair density.
|
Change from Baseline hair density at 12 weeks
|
The change of hair follicle strength
Time Frame: Change from Baseline hair follicle strength at 12 weeks
|
Pull up the hair of the frontal bone, temporal bone and occipital bone (approximately 60 hairs/area) to assess the number of hair loss in each area.
Units: the number of loss hair
|
Change from Baseline hair follicle strength at 12 weeks
|
The change of thumbs nail color
Time Frame: Change from Baseline thumbs nail color at 12 weeks
|
Chroma Meter MM500 was utilized to measure thumbs nail color.
Units: L* index
|
Change from Baseline thumbs nail color at 12 weeks
|
The change of nails appearence
Time Frame: Change from Baseline nails appearence at 12 weeks
|
Picture taken was utilized to record and observe nails appearence.
|
Change from Baseline nails appearence at 12 weeks
|
The change of nails growth
Time Frame: Change from Baseline marking position at 12 weeks
|
Marking the position of middle fingers lunula was utilized to record and observe nails growth.
Units: milimeter
|
Change from Baseline marking position at 12 weeks
|
The degree of nails fragility
Time Frame: Change from Baseline nails fragility at 12 weeks
|
Iron ruler was utilized to evaluate nails fragility.
Picture taken was utilized to record and observe the change of nails fragility.
|
Change from Baseline nails fragility at 12 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The change of self-assessment skin, hair, and nails condition
Time Frame: Change from Baseline skin, hair, and nails condition at 12 weeks
|
A self-assessment questionnaire was collected and evaluate skin, hair, and nails condition
|
Change from Baseline skin, hair, and nails condition at 12 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Chia-Hua Liang, Ph.D., Chia Nan University of Pharmacy & Science
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 4, 2024
Primary Completion (Estimated)
October 31, 2024
Study Completion (Estimated)
December 1, 2024
Study Registration Dates
First Submitted
March 5, 2024
First Submitted That Met QC Criteria
March 5, 2024
First Posted (Actual)
March 12, 2024
Study Record Updates
Last Update Posted (Actual)
March 19, 2024
Last Update Submitted That Met QC Criteria
March 15, 2024
Last Verified
March 1, 2024
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 23-118-B
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Skin Condition
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)TerminatedPrecancerous/Nonmalignant ConditionUnited States
-
AI Labs Group S.LOsakidetza; Hospital Universitario Cruces; Servicio Vasco de Salud Osakidetza...RecruitingSkin Diseases | Skin ConditionSpain
-
TCI Co., Ltd.Recruiting
-
TCI Co., Ltd.Completed
-
TCI Co., Ltd.Completed
-
TCI Co., Ltd.Completed
Clinical Trials on placebo drink
-
Virginia Polytechnic Institute and State UniversityCompletedCardiovascular Risk FactorUnited States
-
University of the PacificCompletedCardiovascular DiseasesUnited States
-
Maastricht University Medical CenterTop Institute Food and NutritionCompletedMuscle Loss in ElderlyNetherlands
-
Mayo ClinicCompletedCardiovascular System | Hemodynamics | Energy DrinksUnited States
-
Wageningen UniversityMaastricht University Medical Center; Top Institute Food and NutritionCompleted
-
University of LimerickCompleted
-
University of LeedsArla FoodsCompletedCognitive Performance (Focus)United Kingdom